127
Views
31
CrossRef citations to date
0
Altmetric
Research Article

Use of porous aluminosilicate pellets for drug delivery

&
Pages 423-437 | Received 02 Aug 2004, Accepted 10 Jan 2005, Published online: 03 Oct 2008

References

  • Bates TF, Hildebrand FA, Swineford A. 1950. Morphology and structure of endellite and halloysite. American Minerals 35:463–485.
  • Bechgaard H, Ladefoged K. 1978. Distribution of pellets in the gastrointestinal tract. The influence of transit time exerted by the density or diameter of pellets. Journal of Pharmaceutical Pharmacology 30:690–692.
  • Bodmeier R, Paeratakul O. 1989. Spherical agglomerates of water-insoluble drugs. Journal of Pharmaceutical Sciences 78:964–967.
  • Buchmuller J, Weyermanns G. 1989. Device for the controlled freezing of viscous liquids. US Patent 4,829,783.
  • Byrne RS, Deasy PB. 2002. Use of commercial porous ceramic particles for sustained drug delivery. International Journal of Pharmaceutics 246:61–73.
  • Deasy PB. 1984. General introduction. In: Microencapsulation and related drug processes. New York: Marcel Dekker, Inc.
  • El-Raheem El- Helw A, El-Said Y. 1988. Preparation and characterization of agar beads containing phenobarbitone sodium. Journal of Microencapsulation 5:159–163.
  • Fabbri M, Celotti GC, Ravaglioli A. 1994. Granulates based on calcium phosphate with controlled morphology and porosity for medical applications: physico-chemical parameters and production technique. Biomaterials 15: 474–477.
  • Gallagher KM, Corrigan OI. 2000. Mechanistic aspects of the release of levamisole hydrochloride from biodegradable polymers. Journal of Controlled Release 69:261–272.
  • Ghebre-Sellassie I. 1989. Pellets: a general overview. In: Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker, Inc.
  • Hicks DC, Freese HL. 1989. Extrusion and spheronizing equipment. In: Ghebre-Sellassie I, editor. Pharmaceutical pelletization technology. New York: Marcel Dekker, Inc.
  • Higuchi T. 1963. Mechanism of sustained-action medication. Journal of Pharmaceutical Sciences 52:1145–1149.
  • Itokazu M, Esaki M, Yamamoto K, Tanemori T, Kasai T. 1999. Local drug delivery system using ceramics: vacuum method for impregnating a chemotherapeutic agent into a porous hydroxyapatite block. Journal of Materials Science—Materials Medicine 10:249–252.
  • Itokazu M, Yang W, Aoki T, Ohara A, Kato N. 1998. Synthesis of antibiotic-loaded hydroxyapatite blocks by vacuum method and in vitro drug release testing. Biomaterials 19:817–819.
  • Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. 1991. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behaviour (in vivo). Journal of Controlled Release 16:279–280.
  • Kibbe AH. 2000. Handbook of pharmaceutical excipients. 3rd ed. Washington: American Pharmaceutical Association; and London: Pharmaceutical Press.
  • Knoch A. 1994. Cryopelletization. In: Ghebre-Sellassie, editor. Multiparticulate oral drug delivery. New York: Marcel Dekker, Inc., pp 35–50.
  • Krajewski A, Ravaglioli A, Roncari E, Pinasco P, Montanan L. 2000. Porous ceramic bodies for drug delivery. Journal of Materials Science-Materials Medicine 12:763–771.
  • Ku CC, Joshi YM, Bergum JS, Jain NB. 1993. Bead manufacture by extrusion-spheronization-a statistical design for process optimization. Drug Development in Industrial Pharmacy 19:1505–1519.
  • Landi E, Orlandi L, Spagna G, Tampieri A, Zaffaroni N. 2000. Calcium phosphate ceramics as drug-delivery system for anticancer therapy. Key English Materials 192:901–904.
  • Levis SR, Deasy PB. 2003. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. International Journal of Pharmaceutics 253:145–157.
  • Martin AN. 1993. Diffusion and dissolution. In: Physical pharmacy. 4th ed. Philadelphia: Lea & Febiger, pp 324–361.
  • Montanaro L, Jorand Y, Fantozzi G, Negro A. 1998. Porous ceramics by powder processing. Journal of the European Ceramic Society 18:1339–1350.
  • Moore DM, Reynolds RC. 1997. Introduction and historical background. In: X-ray diffraction and the identification and analysis of clay minerals. New York: Oxford University Press.
  • Netz DJA, Sepulveda P, Pandolfelli VC, Spadaro ACC, Alencastre JB, Bentley MVLB, Marchetti JM. 2001. Potential use of gelcasting hydroxyapatite porous ceramic as an implantable drug delivery system. International Journal of Pharmaceutics 213:117–125.
  • Paul W, Sharma CP. 1995. Antiobiotic loaded hydroxyapatite osteoconductive implant material-in vitro release studies. Journal of Materials Science Letters 14:1792–1794.
  • Paul W, Nesamony J, Sharma CP. 2002. Delivery of insulin from hydroxyapatite ceramic microspheres: preliminary in vivo studies. Journal of Biomedical Materials Research 61:660–662.
  • Price RR, Gaber BP, Lvov Y. 2001. In-vitro release characteristics of tetracycline HC1, khellin and nicotinamide adenine dineculeotide from halloysite; a cylindrical mineral. Journal of Microencapsulation 18:713–722.
  • Queiroz AC, Santos JD, Monteiro FJ, Gibson IR, Knowles JC. 2001. Adsorption and release studies of sodium ampicillin from hydroxyapatite and glass-reinforced hydroxyapatite composites. Biomaterials 22:1393–1400.
  • Ritger PL, Peppas NA. 1987. A simple equation for description of solute release. I. Fickian and non-Fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. Journal of Controlled Release 5:23–36.
  • Schmedders T, Andresen L, Koch D, Grathwohl G. 2001. Porous materials by freeze-casting. Materials Week, Munich, Germany.
  • Sepulveda P, Binner JGP. 1999. Processing of cellular ceramics by foaming and in situ polymerisation of organic monomers. Journal of the European Ceramics Society 19:2059–2066.
  • Siegel RA. 1989. Modeling of drug release from porous polymers. In: Rosoff M, editor. Controlled release of drugs: Polymers and aggregate systems. New York: VCH Publishers, pp 1–51.
  • van Olphen H. 1963a. Clay mineralogy. In: An introduction to clay colloid chemistry. New York: John Wiley & Sons, Inc., pp 59–88.
  • van Olphen H. 1963b. Electric double-layer structure and stability of clay suspensions. In: An introduction to clay colloid chemistry. New York: John Wiley & Sons, Inc., pp 16–29.
  • Velde B. 1992a. The clay perspective. In: Introduction to clay minerals: Chemistry, origins, uses and environmental significance. London: Chapman and Hall, pp 1–11.
  • Velde B. 1992b. Clays as minerals. In: Introduction to clay minerals: Chemistry, origins, uses and environmental significance. London: Chapman and Hall, pp 41–100.
  • Yamamura K, Yotsuyanagi T. 1992. Adsorption and irreversible binding of adriamycin incorporated into hydroxyapatite beads. International Journal of Pharmaceutics 79:R1–R3.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.